Indaptus Therapeutics, Inc. (INDP)
1.22
+0.16
(+15.09%)
USD |
NASDAQ |
May 22, 16:00
1.24
+0.02
(+1.64%)
After-Hours: 20:00
Indaptus Therapeutics Shareholders Equity (Quarterly) : 1.248M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Agenus, Inc. | -221.22M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Anika Therapeutics, Inc. | 133.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.181M |
| Total Liabilities (Quarterly) | 0.933M |
| Current Ratio | 2.338 |
| Net Debt Paydown Yield | 0.01% |